Works matching DE "MELANOMA treatment"
Results: 2423
Immunotherapy Continues to Make News.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 7, p. 646
- By:
- Publication type:
- Article
Relative Roles of Targeted Therapies and Immunotherapies in Melanoma.
- Published in:
- 2012
- Publication type:
- Interview
Individualized Local Treatment Strategies for In-Transit Melanoma.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 14, p. 1355
- By:
- Publication type:
- Article
Treatment of In-Transit Melanoma: An Opportunity to Discover Critical Knowledge.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 14, p. 1351
- By:
- Publication type:
- Article
In-Transit Melanoma: An Individualized Approach.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 14, p. 1340
- By:
- Publication type:
- Article
A Role for Hepatic Metastasectomy in Stage IV Melanoma and Breast Cancer: Reestablishing the Surgical Modality.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 12, p. 1158
- By:
- Publication type:
- Article
CTLA-4-Blocking Immunotherapy With Ipilimumab for Advanced Melanoma.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 14, p. 1302
- By:
- Publication type:
- Article
Ipilimumab for Advanced Melanoma: Let's Not Throw Caution to the Winds.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 14, p. 1296
- By:
- Publication type:
- Article
Ipilimumab: A Promising Immunotherapy for Melanoma.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 14, p. 1280
- By:
- Publication type:
- Article
Improving the Therapeutic Benefits of Ipilimumab.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 14, p. 1288
- By:
- Publication type:
- Article
Ipilimumab Ups Survival in Metastatic Melanoma Phase III Trial.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 7, p. 648
- Publication type:
- Article
ODAC Recommends Approval of Pegylated Interferon Alfa-2b for Malignant Melanoma.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 11, p. 928
- Publication type:
- Article
Despite Past Disappointments, the Future of Melanoma Therapy Appears Bright.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 6, p. 509
- By:
- Publication type:
- Article
Treating Metastatic Melanoma: Further Considerations.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 6, p. 500
- By:
- Publication type:
- Article
The Pathway Ahead in Melanoma Trials.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 6, p. 496
- By:
- Publication type:
- Article
Fascin-1 expression in canine cutaneous and oral melanocytic tumours.
- Published in:
- Veterinary & Comparative Oncology, 2012, v. 10, n. 4, p. 303, doi. 10.1111/j.1476-5829.2011.00300.x
- By:
- Publication type:
- Article
Abstracts presented at the 28<sup>th</sup> Annual VCS Conference, Seattle, WA, USA, 18–21 October 2008.
- Published in:
- 2009
- Publication type:
- Abstract
Sex Differences in Cutaneous Melanoma: Incidence, Clinicopathological Profile, Survival, and Costs.
- Published in:
- Journal of Women's Health (15409996), 2022, v. 31, n. 7, p. 1012, doi. 10.1089/jwh.2021.0223
- By:
- Publication type:
- Article
Targeted Nanoparticle‐Mediated Gene Therapy Mimics Oncolytic Virus for Effective Melanoma Treatment.
- Published in:
- Advanced Functional Materials, 2018, v. 28, n. 29, p. 1, doi. 10.1002/adfm.201800173
- By:
- Publication type:
- Article
Metastatic melanoma moves on: translational science in the era of personalized medicine.
- Published in:
- Cancer & Metastasis Reviews, 2017, v. 36, n. 1, p. 7, doi. 10.1007/s10555-017-9658-0
- By:
- Publication type:
- Article
The impact of melanoma genetics on treatment response and resistance in clinical and experimental studies.
- Published in:
- Cancer & Metastasis Reviews, 2017, v. 36, n. 1, p. 53, doi. 10.1007/s10555-017-9657-1
- By:
- Publication type:
- Article
Crosstalk signaling in targeted melanoma therapy.
- Published in:
- Cancer & Metastasis Reviews, 2017, v. 36, n. 1, p. 23, doi. 10.1007/s10555-017-9659-z
- By:
- Publication type:
- Article
Identification, genetic testing, and management of hereditary melanoma.
- Published in:
- Cancer & Metastasis Reviews, 2017, v. 36, n. 1, p. 77, doi. 10.1007/s10555-017-9661-5
- By:
- Publication type:
- Article
Precision medicine driven by cancer systems biology.
- Published in:
- Cancer & Metastasis Reviews, 2017, v. 36, n. 1, p. 91, doi. 10.1007/s10555-017-9662-4
- By:
- Publication type:
- Article
How do patients with uveal melanoma experience and manage uncertainty? A qualitative study.
- Published in:
- 2015
- By:
- Publication type:
- journal article
The impact of diagnosis and plaque radiotherapy treatment of malignant choroidal melanoma on patients' quality of life.
- Published in:
- Psycho-Oncology, 2006, v. 15, n. 12, p. 1077, doi. 10.1002/pon.1046
- By:
- Publication type:
- Article
Langfristiges Überleben nach Ipilimumab und hypofraktionierter Ganzhirnbestrahlung bei Hirnmetastasen maligner Melanome: die Reihenfolge ist relevant.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Effective local control of malignant melanoma by intratumoural injection of a beta-emitting radionuclide.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2002, v. 29, n. 2, p. 221, doi. 10.1007/s00259-001-0696-y
- By:
- Publication type:
- Article
Melanoma arising in an ovarian cystic teratoma: a systematic review of presentation, treatment, and outcomes.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Genital melanoma: prognosis factors and treatment modality.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Treatment of Melanoma Metastases Confined to the Liver and Future Perspectives.
- Published in:
- Digestive Surgery, 2008, v. 25, n. 6, p. 467, doi. 10.1159/000184738
- By:
- Publication type:
- Article
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity.
- Published in:
- Nature, 2015, v. 523, n. 7559, p. 231, doi. 10.1038/nature14404
- By:
- Publication type:
- Article
Drug development: A chance of survival.
- Published in:
- Nature, 2014, v. 515, n. 7527, p. S118, doi. 10.1038/515S118a
- By:
- Publication type:
- Article
Cancer immunology: Therapy broadens immune response.
- Published in:
- Nature, 2014, v. 513, n. 7519, p. 462, doi. 10.1038/513462e
- Publication type:
- Article
Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma.
- Published in:
- Nature, 2014, v. 508, n. 7494, p. 118, doi. 10.1038/nature13121
- By:
- Publication type:
- Article
Melanoma drug wins US approval.
- Published in:
- Nature, 2011, v. 471, n. 7340, p. 561, doi. 10.1038/471561a
- By:
- Publication type:
- Article
Nailing the message.
- Published in:
- Podiatrist, 2022, v. 25, n. 2, p. 20
- Publication type:
- Article
Mucosal melanoma of nasal cavity in 89-year-old woman - case report and review of the literature.
- Published in:
- Polish Otorhinolaryngological Review / Polski Przegląd Otorynolaryngologiczny (Index Copernicus), 2020, v. 9, n. 1, p. 1, doi. 10.5604/01.3001.0013.5600
- By:
- Publication type:
- Article
GM-CSF IN ADJUVANT AND CHEMOBIOTHERAPY OF MELANOMA.
- Published in:
- 2004
- Publication type:
- Abstract
Health-related quality of life in patients with advanced metastatic melanoma: results of a randomized phase III study comparing temozolomide with dacarbazine.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Therapy of Melanoma with Allogeneic Melanoma Lysates Alone or with Interferon-Alfa.
- Published in:
- Cancer Investigation, 2002, v. 20, n. 5/6, p. 759, doi. 10.1081/CNV-120002493
- By:
- Publication type:
- Article
Interferon-α Combined with Radiotherapy in the Treatment of Unresectable Melanoma.
- Published in:
- Cancer Investigation, 2001, v. 19, n. 3, p. 261, doi. 10.1081/CNV-100102553
- By:
- Publication type:
- Article
SWOG-9035: ADJUVANT THERAPY WITH AN ALLOGENEIC TUMOR VACCINE IN INTERMEDIATE-THICKNESS, NODE- NEGATIVE MELANOMA.
- Published in:
- 2001
- Publication type:
- Abstract
MAINTENANCE BIOLOGIC THERAPY WITH INTERLEUKIN-2 (IL-2) AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR FOR PATIENTS WITH METASTATIC MELANOMA FOLLOWING MODIFIED CONCURRENT BIOCHEMOTHERAPY.
- Published in:
- 2001
- Publication type:
- Abstract
ADJUVANT THERAPY OF STAGE III AND IV MALIGNANT MELANOMA USING GRANULOCYTE-MACROPHAGE COLONY- STIMULATING FACTOR.
- Published in:
- 2001
- Publication type:
- Abstract
HISTAMINE DIHYDROCHLORIDE AS AN ADJUVANT TO INTERLEUKIN-2 (IL-2) THERAPY IN METASTATIC MELANOMA: RESULTS OF A MULTICENTER, RANDOMIZED, PHASE III TRIAL.
- Published in:
- 2001
- Publication type:
- Abstract
Fisetin induces apoptosis through mitochondrial apoptosis pathway in human uveal melanoma cells.
- Published in:
- Environmental Toxicology, 2018, v. 33, n. 5, p. 527, doi. 10.1002/tox.22538
- By:
- Publication type:
- Article
Diallyl trisulfide inhibits cell migration and invasion of human melanoma a375 cells via inhibiting integrin/facal adhesion kinase pathway.
- Published in:
- Environmental Toxicology, 2017, v. 32, n. 11, p. 2352, doi. 10.1002/tox.22445
- By:
- Publication type:
- Article
Primary anorectal malignant melanoma: rare but highly lethal malignancy.
- Published in:
- Turkish Journal of Medical Sciences, 2012, v. 42, n. S2, p. 1513, doi. 10.3906/sag-1202-62
- By:
- Publication type:
- Article
Preparation and characterization of vemurafenib microemulsion based hydrogel using surface active ionic liquid.
- Published in:
- Pharmacia (0428-0296), 2024, v. 71, n. 1, p. 1, doi. 10.3897/pharmacia.71.e111178
- By:
- Publication type:
- Article